118 related articles for article (PubMed ID: 29388345)
1. A novel class of human 15-LOX-1 inhibitors based on 3-hydroxycoumarin.
Alavi SJ; Sadeghian H; Seyedi SM; Salimi A; Eshghi H
Chem Biol Drug Des; 2018 Jun; 91(6):1125-1132. PubMed ID: 29388345
[TBL] [Abstract][Full Text] [Related]
2. O-prenylated 3-carboxycoumarins as a novel class of 15-LOX-1 inhibitors.
Jabbari A; Mousavian M; Seyedi SM; Bakavoli M; Sadeghian H
PLoS One; 2017; 12(2):e0171789. PubMed ID: 28182779
[TBL] [Abstract][Full Text] [Related]
3. 2-Prenylated m-dimethoxybenzenes as potent inhibitors of 15-lipo-oxygenase: inhibitory mechanism and SAR studies.
Jabbari A; Sadeghian H; Salimi A; Mousavian M; Seyedi SM; Bakavoli M
Chem Biol Drug Des; 2016 Sep; 88(3):460-9. PubMed ID: 27113261
[TBL] [Abstract][Full Text] [Related]
4. Allylphenols as a new class of human 15-lipoxygenase-1 inhibitors.
Alavi SJ; Seyedi SM; Saberi S; Safdari H; Eshghi H; Sadeghian H
Drug Dev Res; 2021 Apr; 82(2):259-266. PubMed ID: 33022099
[TBL] [Abstract][Full Text] [Related]
5. O-prenylated carbostyrils as a novel class of 15-lipoxygenase inhibitors: Synthesis, characterization, and inhibitory assessment.
Alavi SJ; Zebarjadi A; Bafghi MH; Orafai H; Sadeghian H
Chem Biol Drug Des; 2021 Nov; 98(5):894-902. PubMed ID: 34453501
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR studies of mono O-prenylated coumarins as potent 15-lipoxygenase inhibitors.
Iranshahi M; Jabbari A; Orafaie A; Mehri R; Zeraatkar S; Ahmadi T; Alimardani M; Sadeghian H
Eur J Med Chem; 2012 Nov; 57():134-42. PubMed ID: 23047230
[TBL] [Abstract][Full Text] [Related]
7. Identification of 1, 4-Dihydrothieno [3', 2':5, 6]thiopyrano[4, 3-c] pyrazole derivatives as human 5-Lipo-oxygenase inhibitors.
Hu J; Zhu W; Meng H; Liu Y; Wang X; Hu C
Chem Biol Drug Des; 2014 Dec; 84(6):642-7. PubMed ID: 24889744
[TBL] [Abstract][Full Text] [Related]
8. Exploring the 2'-Hydroxy-Chalcone Framework for the Development of Dual Antioxidant and Soybean Lipoxygenase Inhibitory Agents.
Kostopoulou I; Tzani A; Polyzos NI; Karadendrou MA; Kritsi E; Pontiki E; Liargkova T; Hadjipavlou-Litina D; Zoumpoulakis P; Detsi A
Molecules; 2021 May; 26(9):. PubMed ID: 34066803
[TBL] [Abstract][Full Text] [Related]
9. In vitro study of isoflavones and isoflavans as potent inhibitors of human 12- and 15-lipoxygenases.
Mascayano C; Espinosa V; SepĂșlveda-Boza S; Hoobler EK; Perry S
Chem Biol Drug Des; 2013 Sep; 82(3):317-25. PubMed ID: 23663316
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and SAR studies of 3-allyl-4-prenyloxyaniline amides as potent 15-lipoxygenase inhibitors.
Jabbari A; Davoodnejad M; Alimardani M; Assadieskandar A; Sadeghian A; Safdari H; Movaffagh J; Sadeghian H
Bioorg Med Chem; 2012 Sep; 20(18):5518-26. PubMed ID: 22917856
[TBL] [Abstract][Full Text] [Related]
11. Structural modifications of coumarin derivatives: Determination of antioxidant and lipoxygenase (LOX) inhibitory activity.
Roussaki M; Zelianaios K; Kavetsou E; Hamilakis S; Hadjipavlou-Litina D; Kontogiorgis C; Liargkova T; Detsi A
Bioorg Med Chem; 2014 Dec; 22(23):6586-6594. PubMed ID: 25456384
[TBL] [Abstract][Full Text] [Related]
12. A high throughput screen identifies potent and selective inhibitors to human epithelial 15-lipoxygenase-2.
Jameson JB; Kantz A; Schultz L; Kalyanaraman C; Jacobson MP; Maloney DJ; Jadhav A; Simeonov A; Holman TR
PLoS One; 2014; 9(8):e104094. PubMed ID: 25111178
[TBL] [Abstract][Full Text] [Related]
13. Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1.
Eleftheriadis N; Thee S; te Biesebeek J; van der Wouden P; Baas BJ; Dekker FJ
Eur J Med Chem; 2015 Apr; 94():265-75. PubMed ID: 25771032
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
Shen FQ; Wang ZC; Wu SY; Ren SZ; Man RJ; Wang BZ; Zhu HL
Bioorg Med Chem Lett; 2017 Aug; 27(16):3653-3660. PubMed ID: 28720504
[TBL] [Abstract][Full Text] [Related]
15. Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.
Armstrong M; van Hoorebeke C; Horn T; Deschamps J; Freedman JC; Kalyanaraman C; Jacobson MP; Holman T
Bioorg Med Chem; 2016 Nov; 24(21):5380-5387. PubMed ID: 27647374
[TBL] [Abstract][Full Text] [Related]
16. 3-Substituted pyrazoles and 4-substituted triazoles as inhibitors of human 15-lipoxygenase-1.
Pelcman B; Sanin A; Nilsson P; No K; Schaal W; Ăhrman S; Krog-Jensen C; Forsell P; Hallberg A; Larhed M; Boesen T; Kromann H; Vogensen SB; Groth T; Claesson HE
Bioorg Med Chem Lett; 2015 Aug; 25(15):3024-9. PubMed ID: 26037322
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant Activity of 3-[N-(Acylhydrazono)ethyl]-4-hydroxy-coumarins.
Kotali A; Nasiopoulou DA; Tsoleridis CA; Harris PA; Kontogiorgis CA; Hadjipavlou-Litina DJ
Molecules; 2016 Jan; 21(2):138. PubMed ID: 26805812
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
ElBordiny HS; El-Miligy MM; Kassab SE; Daabees H; Mohamed Ali WA; Abdelhamid Mohamed El-Hawash S
Eur J Med Chem; 2018 Feb; 145():594-605. PubMed ID: 29339254
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]